Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 82 results for "cadila healthcare"

Cadila Healthcare: Outcome of board meeting
Money Control

Cadila Healthcare gets stronger after board approves fund raising

Cadila Healthcare gained 0.83% to Rs 529.45 at 10:10 IST on BSE after the company said that its board approved in-principle to raise funds through various routes. Business Standard, 20 hours ago
Cadila Healthcare: Outcome of board meeting Money Control, 21 hours ago
Cadila board approves raising up to Rs 18,500 cr Business Standard, 1 day ago

51 images for cadila healthcare

Money Control, 19 hours ago
Money Control, 21 hours ago
Money Control, 1 week ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Control, 1 week ago
Sify, 2 weeks ago
Sify, 2 weeks ago
Money Control

Zydus Cadila gets USFDA nod for generic Hepatitis B drug

Drug firm Zydus Cadila today said it has received US health regulator's approval to market entecavir tablets, used for treatment of Hepatitis B. The company has received final approval from the US Food and Drug Administration (USFDA) to market entecavir ...
 Business Standard14 hours ago Cadila Healthcare rises 2% on fund raising plan, USFDA approval  Money Control19 hours ago Cadila Healthcare, Jubilant and Biocon are able to grow despite pressures  Business Standard1 day ago Zydus Cadila gets USFDA nod to market migraine drug  DNA1 week ago
[x]  
Money Control

Stocks in the news: Aurobindo, Cadila, Bajaj Hind, Amtek Auto, Sterlite Tech, NOCIL

Aurobindo Pharma | ONGC | Lupin | HPCL | Cadila Healthcare | IDFC | Bajaj Hindustan Sugar | LT Foods | Bhushan Steel | Amtek Auto | Sterlite Technologies | Jyoti Structures | Grasim and NOCIL are stocks, which are in the news today.
 Money Control22 hours ago Stocks in the news: RIL, Aurobindo, Tata Motors, Strides, Titan, Amtek Auto, Cadila  Money Control2 weeks ago Stocks in the news: SBI, Tata Motors, Cadila, Gufic Bio, Everest Organics, CARE  Money Control3 weeks ago
Money Control

Cadila Healthcare aims to double US business to $1 billion in 3 years

Pharma major to launch 100 new products; Moraiya facility slated to come out of US FDA woes
 Business Standard14 hours ago Sun Pharma, Cadila Healthcare recall products from US market  Business Standard2 months ago
Money Control

USFDA audit finds no flaws in Cadila Healthcare Moraiya unit

Plant has received several product approvals after audit. eyes 40 in all in FY18
 Business Standard6 days ago Cadila Healthcare gets healthier after USFDA nod for migraine drug  Business Standard1 week ago Cadila Healthcare gains 2% on USFDA approval for anti-retroviral drug  Money Control1 week ago Cadila Healthcare gains after USFDA nod for antifungal drug  Business Standard2 weeks ago
[x]  

Indian Indices Trade in Red; Metal Stocks Drag

Posted by Equitymaster After opening the day marginally lower, share markets in India have continued the downtrend and are currently trading below the dotted line. Sectoral indices are trading on a mixed note with stocks in the realty sector and stocks in the ...
 Equitymaster.com6 days ago Indian Indices Trade in Red; Pharma Stocks Witness Buying  Equitymaster.com2 weeks ago Share Markets in India Open Flat; Cipla Plunges on Poor Q4 Results  Equitymaster.com1 month ago
First Post.com

Indian investors ride out big-pharma slump with small-cap drugmakers

MUMBAI - Investors in Indianpharmaceutical stock, hit by quality-related sanctions againstdrugmakers operating abroad and reduced pricing power in moreprofitable markets, have adopted a new mantra: patience andpickiness. Fund managers said they are becoming ...
 Sify1 week ago
Money Control

Cadila Healthcare jumps after getting inspection report for Baddi facility

Cadila Healthcare rose 3.10% to Rs 505.70 at 9:26 IST on BSE after the company said its Baddi facility got Establishment Inspection Report from US drug regulator.
 Business Standard3 weeks ago Cadila Healthcare up 4% on establishment inspection report from USFDA for Baddi  Money Control3 weeks ago Cadila Healthcare gets EIR from USFDA for Baddi facility  DNA3 weeks ago Cadila Healthcare at new high on getting EIR from USFDA for Baddi facility  Business Standard3 weeks ago
Money Control

Cadila Healthcare at 1-year high on USFDA approval to market Nystatin Topical Powder

Nystatin Topical Powder is an antifungal antibiotic used to treat skin infections caused by yeast.
 Money Control2 weeks ago

Zydus' Nesher Pharmaceuticals gets FDA nod for antifungal drug

Zydus Group firm Cadila Healthcare today said its subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical powder used for treating skin infections in the US market.
 DNA2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less